# Insight Molecular Diagnostics Inc.: Form SCHEDULE 13D/A, filed Feb 12, 2026

- Company: [Insight Molecular Diagnostics Inc.](/companies/imdx.md) (CIK 1642380)
- Form: SCHEDULE 13D/A
- Filed: 2026-02-12
- Accepted by EDGAR: Feb 12, 2026, 19:52 ET
- Period: not reported
- Accession: 0000919574-26-000780
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1642380/000091957426000780/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1642380/000091957426000780/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1642380/000091957426000780/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 12, 2026.
Source: SEC EDGAR, the filing index for accession 0000919574-26-000780. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.